Fig. 3From: Pharmacogenomic insights into tuberculosis treatment shows the NAT2 genetic variants linked to hepatotoxicity risk: a systematic review and meta-analysisForest plot of ORs with 95% CI of INH-induced hepatotoxicity risk associated with NAT2 for the subgroup ethnicityBack to article page